SPIA
CDTX

Steward Partners Investment Advisory’s Cidara Therapeutics CDTX Stock Holding History

Steward Partners Investment Advisory’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-25
Closed -$1K – 2885
2020
Q3 		$1K Buy
25
+5
+25% +$353 ﹤0.01% 2642
2020
Q2 		$1K Hold
20
– – ﹤0.01% 2543
2020
Q1 		$0 Hold
20
– – ﹤0.01% 2507
2019
Q4 		$1K Hold
20
– – ﹤0.01% 2491
2019
Q3 		$0 Hold
20
– – ﹤0.01% 2622
2019
Q2 		$0 Buy
+20
New +$831 ﹤0.01% 2612
2018
Q4 		– Sell
-50
Closed -$4K – 966
2018
Q3 		$4K Sell
50
-113
-69% -$9.97K ﹤0.01% 2174
2018
Q2 		$17K Buy
+163
New +$15.4K ﹤0.01% 1525

Other funds holding CDTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Steward Partners Investment Advisory's CDTX Position: Q4 2020 in Review

Steward Partners Investment Advisory sold out of Cidara Therapeutics (CDTX) in Q4 2020, closing a stake of 25 shares — an estimated $1K sold.

Steward Partners Investment Advisory first reported a position in CDTX in Q2 2018 and held it in 8 quarters. The position peaked at $17K in Q2 2018. 63 funds tracked by Wall St. Rank hold CDTX as of Q4 2020.

  • Steward Partners Investment Advisory reported no remaining Cidara Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 25 Cidara Therapeutics shares in Q4 2020, an estimated $1K.
  • Steward Partners Investment Advisory first reported a position in Cidara Therapeutics in Q2 2018 and held it in 8 quarters.
  • Steward Partners Investment Advisory's Cidara Therapeutics position peaked at $17K in Q2 2018.
  • 63 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q4 2020.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2020, filed 11 Feb 2021.